30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Medipharm Labs Corp (LABS)

Over the last 90 days, Medipharm Labs Corp. has seen one insider transaction, a sell totaling CAD 13,258.95 by Director Christopher David Taves. This follows previous sell transactions by Directors Keith Strachan and Gregory Edison Hunter in June and August 2023. The stock has experienced a 15.4% price increase over the past 90 days.
Stock chart
Ticker: LABS Exchange: TOR


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Taves, Christopher David
Director of Issuer
1 sale — total 100,000 CAD
Sale 9 Jun 2026
Value CA$2,756,614.98 | Price 32.03 | Shares 23,401
Sale 18 Aug 2023
Value CA$2,986,803.41 | Price 486.66 | Shares 51,618
Sale 22 Jun 2023
Value CA$15,615.84 | Price 0.06 | Shares 260,264
Sale 22 Jun 2023
Value CA$12,675.42 | Price 0.06 | Shares 211,257
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-12 2026-06-09 S Sale

Director of Issuer

Non-Executive Director
23,401 -6.4%
32.03
CA$2,756,615
23,401 -6.4% 32.03 CA$2,756,615
2023-08-23 2023-08-18 S Sale

Director of Issuer

Non-Executive Director
51,618 -48.1%
486.66
CA$2,986,803
51,618 -48.1% 486.66 CA$2,986,803
2023-06-30 2023-06-22 S Sale

Director of Issuer

Non-Executive Director
5,544 -31.1%
58.75
CA$3,451,024
5,544 -31.1% 58.75 CA$3,451,024
2023-06-27 2023-06-22 S Sale

Senior Officer of Issuer

Officer
211,257 -28.2%
0.06
CA$12,675
211,257 -28.2% 0.06 CA$12,675